CHC22 clathrin mediates traffic from early secretory compartments for human GLUT4 pathway biogenesis

Author:

Camus Stéphane M.123,Camus Marine D.123,Figueras-Novoa Carmen3,Boncompain Gaelle4ORCID,Sadacca L. Amanda3,Esk Christopher5ORCID,Bigot Anne6,Gould Gwyn W.7ORCID,Kioumourtzoglou Dimitrios78,Perez Franck4ORCID,Bryant Nia J.8,Mukherjee Shaeri2ORCID,Brodsky Frances M.123ORCID

Affiliation:

1. Department of Bioengineering and Therapeutic Sciences and Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA

2. Department of Microbiology and Immunology and the G.W. Hooper Foundation, University of California, San Francisco, San Francisco, CA

3. Division of Biosciences, University College London, London, UK

4. Institut Curie, PSL Research University, CNRS UMR 144, Paris, France

5. Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria

6. Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, Association Institut de Myologie, UMR S974 Centre for Research in Myology, Paris, France

7. Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK

8. Department of Biology and York Biomedical Research Institute, University of York, York, UK

Abstract

Glucose transporter 4 (GLUT4) is sequestered inside muscle and fat and then released by vesicle traffic to the cell surface in response to postprandial insulin for blood glucose clearance. Here, we map the biogenesis of this GLUT4 traffic pathway in humans, which involves clathrin isoform CHC22. We observe that GLUT4 transits through the early secretory pathway more slowly than the constitutively secreted GLUT1 transporter and localize CHC22 to the ER-to-Golgi intermediate compartment (ERGIC). CHC22 functions in transport from the ERGIC, as demonstrated by an essential role in forming the replication vacuole of Legionella pneumophila bacteria, which requires ERGIC-derived membrane. CHC22 complexes with ERGIC tether p115, GLUT4, and sortilin, and downregulation of either p115 or CHC22, but not GM130 or sortilin, abrogates insulin-responsive GLUT4 release. This indicates that CHC22 traffic initiates human GLUT4 sequestration from the ERGIC and defines a role for CHC22 in addition to retrograde sorting of GLUT4 after endocytic recapture, enhancing pathways for GLUT4 sequestration in humans relative to mice, which lack CHC22.

Funder

National Institutes of Health

Wellcome Trust

Medical Research Council

American Heart Association

Pew Charitable Trusts

Diabetes UK

Centre National de la Recherche Scientifique

Fondation pour la Recherche Médicale

Agence Nationale de la Recherche

Labex

Paris Sciences et Lettres

Publisher

Rockefeller University Press

Subject

Cell Biology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3